Conflicts of Interest Regarding ECT Covers Up Damage

Excerpted from CCHR’s submission to the FDA opposing its 2015 proposal to reclassify the ECT device as a Class II low risk device. CCHR’s submission was submitted in March 2016. The Food and Drug Administration (FDA) Proposal in 2015 to reduce the risk classification of the ECT device instead of banning it, is of enormous … Read more Conflicts of Interest Regarding ECT Covers Up Damage